Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a decrease in first-quarter 2023 adjusted earnings and revenues. The company also provided guidance for
ABBV Infographic: AbbVie’s Q1 2023 earnings and revenue decline
Categories
Health Care
Eli Lilly and Company (LLY) Q1 2023 Earnings Call Transcript
Eli Lilly and Company (NYSE: LLY) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Joe Fletcher -- Senior Vice President
AbbVie (ABBV) Q1 2023 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Elizabeth Shea -- Senior Vice President of Investor Relations
Quest Diagnostics Inc (DGX) Q1 2023 Earnings Call Transcript
Quest Diagnostics Inc (NYSE: DGX) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Shawn Bevec -- VP, Investor Relations James E. Davis -- Chairman,
Edwards Lifesciences Corporation (EW) Q1 2023 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE: EW) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Mark Wilterding -- Senior Vice President, Investor Relations and
BioMarin Pharmaceutical Inc (BMRN) Q1 2023 Earnings Call Transcript
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Traci McCarty -- Group Vice President, Investor Relations Jean-Jacques
Thermo Fisher Scientific Inc (TMO) Q1 2023 Earnings Call Transcript
Thermo Fisher Scientific Inc (NYSE: TMO) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Rafael Tejada -- Vice President Investor Relations Marc
Humana Inc (HUM) Q1 2023 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Lisa Stoner -- Vice President, Investor Relations Bruce D. Broussard -- President
Boston Scientific Corp (BSX) Q1 2023 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
BSX Earnings: Highlights of Boston Scientific’s Q1 2023 results
Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the first quarter of 2023. The company also provided guidance for
Infographic: How Thermo Fisher Scientific (TMO) performed in Q1 2023
Thermo Fisher Scientific Inc. (NYSE: TMO) reported first quarter 2023 earnings results today. Revenue was $10.71 billion, down 9% from the same
Novartis AG (NVS) Q1 2023 Earnings Call Transcript
Novartis AG (NYSE:NVS) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant Narasimhan — Chief Executive
Biogen Inc (BIIB) Q1 2023 Earnings Call Transcript
Biogen Inc (NASDAQ:BIIB) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Chuck Triano -- Head of Investor Relations Christopher Viehbacher -- President and Chief
GE Healthcare (GE) Q1 2023 Earnings Call Transcript
GE Healthcare (NYSE:GE) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Carolynne Borders -- Chief Investor Relations Officer Peter J. Arduini -- President
Centene Corporation (CNC) Q1 2023 Earnings Call Transcript
Centene Corporation (NYSE: CNC) Q1 2023 earnings call dated Apr. 25, 2023 Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance and Investor Relations
Illumina Inc (ILMN) Q1 2023 Earnings Call Transcript
Illumina Inc (NASDAQ: ILMN) Q1 2023 earnings call dated Apr. 25, 2023 Corporate Participants: Salli Schwartz -- Vice President of Investor Relations Francis deSouza -- Chief
Everything you need to know about Biogen’s (BIIB) Q1 2023 earnings
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the first quarter of 2023. Total
Ocean Biomedical co-founder Jonathan Kurtis presents detailed data on malaria vaccine at conference
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and commercializing their
Centene Corporation (CNC) Q1 2023 Earnings Summary
Centene Corporation (NYSE: CNC) reported total revenue of $38.8 billion compared to $37.1 billion in the same period a year ago. Net
Rite Aid Corporation (RAD) Q4 2023 Earnings Call Transcript
Rite Aid Corporation (NYSE: RAD) Q4 2023 earnings call dated Apr. 20, 2023 Corporate Participants: Byron Purcell -- Vice President of Investor Relations &
Rite Aid Corporation (RAD) Q4 2023 net loss narrows
Drugstore chain Rite Aid Corporation (NYSE: RAD) announced fourth-quarter 2023 results, reporting a modest increase in revenues and a narrower net loss.